Meeting
2023 ASCO Genitourinary Cancers Symposium
Patient perceptions regarding the process of obtaining oral prostate cancer medications.
Authors
Eric B Schwartz
Kaiser Permanente, Lafayette, CO
Eric B Schwartz , Allison Furgal , Gina Widmer , Megan Veresh Caram , Christine M Veenstra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 120)
DOI
10.1200/JCO.2023.41.6_suppl.120
Abstract #
120
Poster Bd #
E8
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Associations between costs of oral hormonal therapies for prostate cancer, financial assistance mechanisms, and time on treatment.
First Author: Eric B Schwartz
Poster
2021 Genitourinary Cancers Symposium
Evaluating financial burdens of oral hormonal therapies for patients with prostate cancer.
First Author: Eric B Schwartz
Poster
2024 ASCO Genitourinary Cancers Symposium
Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.
First Author: David Joseph Benjamin
Poster
2024 ASCO Genitourinary Cancers Symposium
Interaction of age and benefit of treatment intensification in advanced prostate cancer: An aggregate meta-analysis of 14 randomized trials.
First Author: Alicia K. Morgans